Nureca Share Price
305.05+6.55 (+2.19%)
+16.65% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
LENSKARTNSE
MOLBIONSE
POLYMEDNSE
SMTNSE
QLINE-SMNSE
3BBLACKBIONSE
LAXMIDENTLNSE
OSELDEVICE-SMNSE
NURECA-BENSE
YASHOPTICS-SMNSE
Nureca Share Price
305.05+6.55 (+2.19%)
+16.65% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | -7% | 10% | 34% |
| - | -46% | - | 146% |
| - | -30% | -6% | 14% |
| 80% | 4% | 0% | 1% |
Peer Comparison
Symbol
LENSKART
MOLBIO
POLYMED
SMT
QLINE-SM
3BBLACKBIO
LAXMIDENTL
OSELDEVICE-SM
NURECA-BE
YASHOPTICS-SM
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 676.15 | ₹115707 Cr | 176.55 | 1.28 | 10.18 | ₹494 Cr |
| 1,341.6 | ₹15126 Cr | 90.79 | 5.21 | 19.98 | ₹167 Cr |
| 1,487.1 | ₹15089 Cr | 47.89 | 8.49 | 43.73 | ₹322 Cr |
| 458.5 | ₹4674 Cr | 71.6 | — | 13.72 | ₹65 Cr |
| 536.9 | ₹1173 Cr | 21.06 | 21.76 | 28.51 | ₹56 Cr |
| 1,343.7 | ₹1124 Cr | 20.24 | 11.13 | 71.91 | ₹60 Cr |
| 184.84 | ₹989 Cr | 32.03 | 1.87 | 8.63 | ₹29 Cr |
| 342.3 | ₹589 Cr | 20.17 | 7.95 | 17.12 | ₹29 Cr |
| 305.05 | ₹289 Cr | 60.72 | 4.25 | 7.46 | ₹2 Cr |
| 112.55 | ₹279 Cr | 30.81 | — | 4.71 | ₹9 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹59 Cr | ₹40 Cr | ₹35 Cr | ₹40 Cr | ₹38 Cr | ₹34 Cr | ₹32 Cr | ₹26 Cr | ₹31 Cr | ₹20 Cr | ₹17 Cr | ₹22 Cr | ₹31 Cr | ₹21 Cr | ₹21 Cr | ₹28 Cr | ₹37 Cr | ₹26 Cr | ₹41 Cr | ₹48 Cr | ₹47 Cr | ₹119 Cr | ₹32 Cr | ₹59 Cr | ₹92 Cr | ₹30 Cr | ₹33 Cr |
| ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹6 Cr | -₹1 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹71 L | ₹66 L | ₹16 L | ₹5 L |
| ₹60 Cr | ₹42 Cr | ₹36 Cr | ₹42 Cr | ₹40 Cr | ₹37 Cr | ₹34 Cr | ₹28 Cr | ₹34 Cr | ₹26 Cr | ₹16 Cr | ₹28 Cr | ₹35 Cr | ₹24 Cr | ₹23 Cr | ₹30 Cr | ₹39 Cr | ₹27 Cr | ₹43 Cr | ₹50 Cr | ₹49 Cr | ₹122 Cr | ₹33 Cr | ₹60 Cr | ₹93 Cr | ₹30 Cr | ₹33 Cr |
| ₹54 Cr | ₹38 Cr | ₹42 Cr | ₹37 Cr | ₹35 Cr | ₹35 Cr | ₹31 Cr | ₹31 Cr | ₹34 Cr | ₹23 Cr | ₹22 Cr | ₹27 Cr | ₹31 Cr | ₹25 Cr | ₹25 Cr | ₹29 Cr | ₹42 Cr | ₹32 Cr | ₹44 Cr | ₹43 Cr | ₹41 Cr | ₹73 Cr | ₹28 Cr | ₹52 Cr | ₹56 Cr | ₹17 Cr | ₹29 Cr |
| ₹7 Cr | ₹5 Cr | -₹5 Cr | ₹5 Cr | ₹6 Cr | ₹2 Cr | ₹3 Cr | -₹3 Cr | ₹81 L | ₹3 Cr | -₹6 Cr | ₹2 Cr | ₹5 Cr | -₹23 L | -₹1 Cr | ₹98 L | -₹3 Cr | -₹5 Cr | -₹1 Cr | ₹7 Cr | ₹8 Cr | ₹49 Cr | ₹6 Cr | ₹9 Cr | ₹37 Cr | ₹13 Cr | ₹4 Cr |
| ₹26 L | ₹20 L | ₹30 L | ₹28 L | ₹46 L | ₹25 L | ₹62 L | ₹18 L | ₹27 L | ₹15 L | ₹18 L | ₹11 L | ₹8 L | ₹12 L | ₹10 L | ₹11 L | ₹10 L | ₹14 L | ₹29 L | ₹11 L | ₹12 L | ₹22 L | ₹38 L | ₹4 L | ₹82 L | ₹36 L | ₹38 L |
| ₹6 Cr | ₹4 Cr | -₹6 Cr | ₹5 Cr | ₹5 Cr | ₹1 Cr | ₹2 Cr | -₹3 Cr | -₹8 L | ₹3 Cr | -₹6 Cr | ₹95 L | ₹4 Cr | -₹93 L | -₹2 Cr | ₹27 L | -₹4 Cr | -₹5 Cr | -₹2 Cr | ₹6 Cr | ₹8 Cr | ₹49 Cr | ₹5 Cr | ₹8 Cr | ₹36 Cr | ₹13 Cr | ₹3 Cr |
| ₹4 Cr | ₹3 Cr | -₹6 Cr | ₹4 Cr | ₹4 Cr | ₹81 L | ₹2 Cr | -₹3 Cr | -₹48 L | ₹2 Cr | -₹4 Cr | ₹17 L | ₹3 Cr | -₹71 L | -₹2 Cr | ₹30 L | -₹3 Cr | -₹4 Cr | -₹1 Cr | ₹5 Cr | ₹5 Cr | ₹36 Cr | ₹4 Cr | ₹6 Cr | ₹27 Cr | ₹9 Cr | ₹2 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — |
| ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹1 L | ₹1 L | ₹1 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1 Cr | ₹99 L | ₹99 L |
| ₹171 Cr | ₹184 Cr | ₹183 Cr | ₹185 Cr | ₹193 Cr | ₹153 Cr | ₹14 Cr | ₹7 Cr | ₹72 L |
| ₹171 Cr | ₹184 Cr | ₹183 Cr | ₹185 Cr | ₹193 Cr | ₹153 Cr | ₹14 Cr | ₹7 Cr | ₹72 L |
| ₹181 Cr | ₹194 Cr | ₹193 Cr | ₹195 Cr | ₹203 Cr | ₹163 Cr | ₹15 Cr | ₹8 Cr | ₹2 Cr |
| ₹22 L | ₹1 Cr | ₹33 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹78 L | ₹9 Cr | ₹26 L | ₹0 |
| -₹3 Cr | -₹3 Cr | -₹5 Cr | -₹3 Cr | -₹10 L | -₹55 L | -₹4 L | -₹90,000 | -₹20,000 |
| ₹61 L | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹0 | ₹0 | ₹0 |
| ₹79 L | ₹70 L | ₹98 L | ₹79 L | ₹41 L | ₹45 L | ₹10 L | ₹3 L | ₹70,000 |
| -₹92 L | -₹18 L | -₹2 Cr | ₹9 L | ₹4 Cr | ₹3 Cr | ₹9 Cr | ₹28 L | ₹50,000 |
| — | — | — | — | — | — | — | — | — |
| ₹5 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹9 Cr | ₹6 Cr | ₹10 Cr | ₹5 Cr |
| ₹8 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹1 Cr | ₹6 Cr | ₹2 L |
| ₹5 L | ₹85 L | ₹8 L | ₹8 L | ₹8 L | ₹22 L | ₹8 L | ₹0 | ₹0 |
| ₹1 Cr | ₹31 L | ₹1 Cr | ₹30 L | ₹35 Cr | ₹10 Cr | ₹2 Cr | ₹2 L | ₹60,000 |
| ₹14 Cr | ₹12 Cr | ₹9 Cr | ₹9 Cr | ₹45 Cr | ₹24 Cr | ₹10 Cr | ₹15 Cr | ₹5 Cr |
| ₹194 Cr | ₹207 Cr | ₹200 Cr | ₹204 Cr | ₹252 Cr | ₹190 Cr | ₹34 Cr | ₹24 Cr | ₹7 Cr |
| ₹5 Cr | ₹2 L | ₹2 L | ₹2 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹72 L | ₹2 Cr | ₹48 L | ₹8 L | ₹8 L | ₹1 Cr | ₹10 Cr | ₹43 L | ₹0 |
| — | — | — | — | — | — | — | — | — |
| ₹21 Cr | ₹14 Cr | ₹10 Cr | ₹11 Cr | ₹12 Cr | ₹4 Cr | ₹1 Cr | ₹61 L | ₹3 L |
| ₹7 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹20 L | ₹8 L | ₹6 L | ₹60,000 |
| ₹14 Cr | ₹9 Cr | ₹7 Cr | ₹9 Cr | ₹10 Cr | ₹4 Cr | ₹1 Cr | ₹54 L | ₹2 L |
| ₹0 | ₹0 | ₹27 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹88 L | ₹4 Cr | ₹29 L | ₹1 Cr | ₹27 L | ₹10 L | ₹3 L | ₹20,000 | ₹20,000 |
| ₹64 Cr | ₹4 Cr | ₹0 | ₹7 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹79 Cr | ₹17 Cr | ₹8 Cr | ₹17 Cr | ₹13 Cr | ₹4 Cr | ₹1 Cr | ₹55 L | ₹2 L |
| — | — | — | — | — | — | — | — | — |
| ₹1 Cr | ₹1 Cr | ₹94 Cr | ₹59 Cr | ₹33 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹48 Cr | ₹40 Cr | ₹31 Cr | ₹34 Cr | ₹63 Cr | ₹37 Cr | ₹16 Cr | ₹14 Cr | ₹4 Cr |
| ₹8 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹22 L | ₹13 Cr | ₹9 Cr | ₹2 Cr |
| ₹41 Cr | ₹127 Cr | ₹45 Cr | ₹71 Cr | ₹84 Cr | ₹127 Cr | ₹7 L | ₹11 L | ₹7 L |
| ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹8 Cr | ₹7 Cr | ₹2 Cr | ₹60,000 | ₹1 Cr |
| ₹15 Cr | ₹16 Cr | ₹17 Cr | ₹14 Cr | ₹48 Cr | ₹16 Cr | ₹1 Cr | ₹45 L | ₹21 L |
| ₹115 Cr | ₹190 Cr | ₹193 Cr | ₹187 Cr | ₹239 Cr | ₹186 Cr | ₹33 Cr | ₹23 Cr | ₹7 Cr |
| ₹101 Cr | ₹178 Cr | ₹183 Cr | ₹178 Cr | ₹194 Cr | ₹162 Cr | ₹23 Cr | ₹8 Cr | ₹2 Cr |
| ₹194 Cr | ₹207 Cr | ₹200 Cr | ₹204 Cr | ₹252 Cr | ₹190 Cr | ₹34 Cr | ₹24 Cr | ₹7 Cr |
| ₹189 | ₹194 | ₹193 | ₹195 | ₹203 | ₹163 | ₹13,935 | ₹6,955 | ₹730 |
| ₹189 | ₹194 | ₹193 | ₹195 | ₹203 | ₹163 | ₹1,991 | ₹994 | ₹104 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| ₹5 Cr | ₹1 Cr | -₹3 Cr | -₹11 Cr | ₹61 Cr | ₹62 Cr | ₹9 Cr | ₹9 Cr | ₹4 Cr |
| ₹5 Cr | -₹9 Cr | -₹7 Cr | -₹3 Cr | -₹4 Cr | ₹11 L | ₹1 Cr | ₹30 L | ₹3 L |
| -₹7 Cr | -₹10 Cr | ₹5 Cr | ₹29 Cr | -₹38 Cr | -₹13 Cr | -₹18 Cr | -₹9 Cr | -₹4 Cr |
| ₹3 Cr | -₹18 Cr | -₹4 Cr | ₹14 Cr | ₹19 Cr | ₹50 Cr | -₹8 Cr | ₹31 L | ₹10 L |
| ₹3 Cr | -₹19 Cr | -₹3 Cr | ₹10 Cr | ₹1 Cr | ₹35 Cr | -₹8 Cr | ₹31 L | ₹10 L |
| ₹14 Cr | ₹8 Cr | ₹18 Cr | -₹16 Cr | -₹3 Cr | -₹110 Cr | -₹39 L | -₹12 L | -₹2 L |
| -₹20 Cr | -₹17 L | -₹1 Cr | -₹2 Cr | -₹7 Cr | ₹92 Cr | ₹8 Cr | -₹14 L | -₹6 L |
| -₹2 Cr | -₹11 Cr | ₹14 Cr | -₹8 Cr | -₹9 Cr | ₹17 Cr | -₹4 L | ₹4 L | ₹2 L |
| ₹3 Cr | ₹14 Cr | ₹50 L | ₹8 Cr | ₹17 Cr | ₹7 L | ₹11 L | ₹7 L | ₹5 L |
| -₹70,000 | -₹80,000 | -₹30,000 | -₹90,000 | -₹10,000 | ₹20,000 | ₹40,000 | -₹10,000 | ₹0 |
| ₹1 Cr | ₹3 Cr | ₹14 Cr | ₹50 L | ₹8 Cr | ₹17 Cr | ₹7 L | ₹11 L | ₹7 L |
Fundamental Ratios
Consolidated
Standalone
No results found
Nureca Share Price
305.05+6.55 (+2.19%)
+16.65% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 5 out of 9 oscillators
RSI
42.16Sell
STOCH %K
29.76Neutral
MACD Level(12,26)
-9.14Sell
Ultimate Oscillator
40.96Sell
Aroon Oscillator
-42.00Sell
BOP
0.58Buy
CCI
-84.29Neutral
Williams %R
-70.24Neutral
Momentum
-18.35Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
306.02Sell
SMA 9
306.54Sell
EMA 21
315.87Sell
SMA 21
318.77Sell
EMA 50
319.73Sell
SMA 50
326.95Sell
EMA 200
293.73Buy
SMA 200
286.10Buy
WMA 20
311.10Sell
Pivot
Pivot
Classic
Resistance 5
360.40
Resistance 4
344.50
Resistance 3
328.60
Resistance 2
312.70
Resistance 1
305.60
Pivot
296.80
Support 1
289.70
Support 2
280.90
Support 3
265.00
Support 4
249.10
Support 5
233.20
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Nureca Share Price
305.05+6.55 (+2.19%)
+16.65% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 70.68% | 68.09% | 68.09% | 68.09% | 64.97% | 64.33% |
| 0.22% | 0.11% | 0.28% | 0.09% | 0.07% | 0.07% |
| 0.20% | 0.20% | 0.20% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 28.90% | 31.60% | 31.43% | 31.82% | 34.96% | 35.60% |
Bulk & block deals
Name
Swathitha Sivakumar
Aakraya Research Llp
Aakraya Research Llp
Copthall Mauritius Investment Limited
Elixir Wealth Management Private Limited
Elixir Wealth Management Private Limited
N V Investments
Elixir Wealth Management Private Limited
Mudupulavemula Surendranadha Reddy
Nk Securities Research Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 29 Oct 2025 | Sell | 2.05 Cr | ₹263.96 | 77.76 K | Bulk | 0.777594 | NSE |
| 15 Jan 2025 | Sell | 2.62 Cr | ₹409.84 | 63.94 K | Bulk | 0.639357 | NSE |
| 15 Jan 2025 | Purchase | 2.62 Cr | ₹409.49 | 63.94 K | Bulk | 0.639357 | NSE |
| 15 Jan 2025 | Purchase | 4.69 Cr | ₹401.94 | 1.17 L | Bulk | 1.167087 | NSE |
| 14 Jan 2025 | Purchase | 1.86 Cr | ₹360.28 | 51.68 K | Bulk | 0.51678 | NSE |
| 14 Jan 2025 | Sell | 2.39 Cr | ₹363.99 | 65.68 K | Bulk | 0.656777 | NSE |
| 10 Jan 2025 | Purchase | 5.67 Cr | ₹358.81 | 1.58 L | Bulk | 1.579968 | NSE |
| 10 Jan 2025 | Purchase | 1.93 Cr | ₹374.42 | 51.55 K | Bulk | 0.51547 | NSE |
| 10 Jan 2025 | Sell | 3.47 Cr | ₹362.41 | 95.87 K | Bulk | 0.958651 | NSE |
| 10 Jan 2025 | Sell | 2.38 Cr | ₹368.22 | 64.56 K | Bulk | 0.645617 | NSE |
Insider trading & SAST
Client name
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
Saurabh Goyal
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 01 Oct 2026 | Promoter | Acquisition | 0.113678 | 70.2 | 42.06 L | ₹369.98 | 11.37 K | 30 Sep 2026 | Market Purchase | 66,98,709 | Insider Trading | — | Equity |
| 30 Sep 2026 | Promoter | Acquisition | 0.030999 | 70.08 | 11.19 L | ₹360.95 | 3.10 K | 29 Sep 2026 | Market Purchase | 66,87,341 | Insider Trading | — | Equity |
| 29 Sep 2026 | Promoter | Acquisition | 0.056179 | 70.05 | 20.04 L | ₹356.69 | 5.62 K | 28 Sep 2026 | Market Purchase | 66,84,241 | Insider Trading | — | Equity |
| 28 Sep 2026 | Promoter | Acquisition | 0.056139 | 69.99 | 19.46 L | ₹346.63 | 5.61 K | 25 Sep 2026 | Market Purchase | 66,78,623 | Insider Trading | — | Equity |
| 26 Sep 2026 | Promoter | Acquisition | 0.00216 | 69.93 | 74.36 K | ₹344.28 | 216 | 24 Sep 2026 | Market Purchase | 66,73,009 | Insider Trading | — | Equity |
| 26 Sep 2026 | Promoter | Acquisition | 0.0243 | 69.93 | 8.37 L | ₹344.24 | 2.43 K | 24 Sep 2026 | Market Purchase | 66,72,793 | Insider Trading | — | Equity |
| 25 Sep 2026 | Promoter | Acquisition | 0.00761 | 69.9 | 2.63 L | ₹345.75 | 761 | 18 Sep 2026 | Market Purchase | 66,69,913 | Insider Trading | — | Equity |
| 25 Sep 2026 | Promoter | Acquisition | 0.055689 | 69.68 | 18.68 L | ₹335.42 | 5.57 K | 16 Sep 2026 | Market Purchase | 66,49,026 | Insider Trading | — | Equity |
| 25 Sep 2026 | Promoter | Acquisition | 0.193796 | 69.89 | 67.35 L | ₹347.54 | 19.38 K | 18 Sep 2026 | Market Purchase | 66,69,152 | Insider Trading | — | Equity |
| 25 Sep 2026 | Promoter | Acquisition | 0.001 | 69.62 | 34.80 K | ₹348 | 100 | 10 Sep 2026 | Market Purchase | 66,43,457 | Insider Trading | — | Equity |
Nureca Share Price
305.05+6.55 (+2.19%)
+16.65% past 1 Year
Nureca Limited is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with
Corporate Actions
Date
Type
Details
Company details
Nureca Share Price
305.05+6.55 (+2.19%)
+16.65% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Nureca Share Price
305.05+6.55 (+2.19%)
+16.65% past 1 Year
News
Nureca Limited Reports Q3 FY26 Profit of Rs 3.20 Crores, Revenue Up 46% YoY to Rs 39.60 Crores.
Equity
NURECA
Nureca Limited Board to Discuss Share Buyback Proposal in Scheduled Meeting on 28th November 2025.
Equity
NURECA
Nureca: Co Reports 87% Growth For Q4 Fy25, Expands Reach With Swiggy And Release Strategic Priorities For Fy 26
Equity
NURECA
Nureca Ltd. - Quaterly Results
Equity
NURECA
Nureca Ltd. - Quaterly Results
Equity
NURECA
Nureca Ltd. reports Profit after tax of 2.07 Crores, in the March 2025 quarter
Equity
NURECA
Nureca expands quick commerce reach with Dr Trust products now available on Swiggy Instamart
Equity
NURECA
Nureca: Co Expands Quick Commerce Reach With Dr Trust Products Now Available On Swiggy Instamart
Equity
NURECA
Nureca gains on getting nod to set up new manufacturing facility in Punjab
Equity
NURECA
Nureca gets nod to set up new manufacturing facility in Punjab
Equity
NURECA
Nureca: Co Gets Formal Approval For Setting Up Of Manufacturing Facility In Sundra, Punjab || New Unit To Manufacture Health And Wellness Equipment
Equity
NURECA
Nureca’s manufacturing arm completes annual registration with USFDA
Equity
NURECA
Nureca: Co’S Manufacturing Subsidiary Secures Us Fda Registration Nureca Technologies Pvt Ltd Expands Global Reach In Medical Devices
Equity
NURECA
Nureca soars on getting nod to purchase land in India
Equity
NURECA
Nureca gets nod to purchase land in India
Equity
NURECA
Nureca informs about disclosure
Equity
NURECA
Nureca Ltd. reports Profit after tax of Rs -3.29 Crores, in the December 2024 quarter
Equity
NURECA
Nureca Ltd. - Quaterly Results
Equity
NURECA
Nureca Ltd. - Quaterly Results
Equity
NURECA
Nureca Ltd. - Quaterly Results
Equity
NURECA